vialroom

#semaglutide 2026-01-31

Saturday47 messages10 participantstimes are UTC
Highlights from this day
  • fake_tracking — i stayed on 1.7 for 13 months and never went to 2.4, appetite was already where i needed it, not advice obviously 16:12
  • electrolyte_eli — vial units and pen clicks are different systems, mixing the two is how people end up wrong 16:51
  • electrolyte_eli — does moving my dose day by two days matter with a seven day half life 17:02
  • egfr_ed — is there a reason to hold at 1.7 rather than going to 2.4 17:45
  • wrong_network — slightly off topic but FLOW was the kidney outcomes trial and it gets quoted in here for things it didnt measure 19:51
FT

£120 a month for compounded against what brand costs locally is why most people here use vials

my Janoshik report on the WWB vial came back 99 against a certificate saying 99.4, take that with a pinch of salt

i stayed on 1.7 for 13 months and never went to 2.4, appetite was already where i needed it, not advice obviously

🙏171👍8
EE

going slow cost me nothing except time and saved me two bad weeks, thats my whole contribution

FT

if youre comparing brand to compounded, dose accuracy in the vial is the variable, not the molecule, n of 1 obviously

👍5📉5
SB

went 1 to 1.7 too fast and spent two weeks regretting it, dropped back and repeated the step

EE

vial units and pen clicks are different systems, mixing the two is how people end up wrong

👀17🤝3
EE

my 30 vial in 2.5ml gives 4mg/ml so 1.7 lands on 50 units, thats why i picked that volume

does moving my dose day by two days matter with a seven day half life

🔥3🤝17

how many weeks before you noticed anything at 12

went too fast once

LN

did anybody find a difference between GGPeps and pharmacy at the same 1

⚠️2

right so changed my mind on the four week rule, i think it depends entirely on how the current dose feels

LN

the trials titrated on a fixed schedule, most people here dont, worth remembering when comparing

Cited study
Once-Weekly Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes (STEP 2)
The Lancet · 2021
The type 2 diabetes population, where the weight response is generally smaller.
CC

the appetite effect faded for me around 4 months and going up fixed it for a while

EE

quick one moving my dose day by a day or two never did anything noticeable for me

EE

is there a reason to hold at 1.7 rather than going to 2.4

🔥15💀2😂1

im at 10 and stuck, did anyone break a plateau without going up

VV

SELECT was cardiovascular outcomes in people with overweight and existing disease, not a weight trial

WN

five week steps worked better for me than four, purely on how the second week felt

my plateau was the scale stopping while appetite stayed suppressed, which is a different problem

does the licensed ceiling for weight differ from the diabetes one

TW

i was wrong about the ceiling for a year, i thought 3 existed. it doesnt for the weight indication

TW

STEP 4 had the withdrawal arm, thats the one people quote when they talk about stopping

WN

sorry to jump in STEP is several trials, so saying STEP said x is usually wrong without a number after it

VV

steady state is the bit people skip, judging a new dose after eight days tells you almost nothing

VV

unrelated but compounded and brand felt the same to me at 0.25, which is one person and nothing more

VV

dose day is sunday for me only because thats when i remember, not because sunday matters

TW

went to 2.4 and the extra suppression wasnt worth the GI for me, so i came back down, anyway

SELECT wasnt weight, not advice obviously

CC

while im here is the plateau usually appetite coming back or just the scale stopping